KSCMS @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – Practical management of Hypertension in Korean after SPRINT trial

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses. Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies to introduce important Chinese academic research.

At the 28th GW-ICC in 2017, the Korean Society of Cardio metabolic Syndrome (KSCMS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Practical management of Hypertension in Korean after SPRINT trial

Presenter: Sang-Hyun Ihm, MD, PhD, Department of Internal Medicine, Catholic University of Korea, Seoul, South Korea.

Dr Sang-Hyun Ihm discusses:

  • Target BP of recent guidelines.
  • Observational studies – lower is better.
  • Updated systemic review and meta analysis.
  • Systolic blood pressure intervention trial (SPRINT).
  • Several issues of SPRINT.

Concluding that:

  • Since AOBP is not generally available in clinical practice, the definition of hypertension should remain BPs >140/90mm Hg.
  • AOBP will be the preferred method of performing in-office BP measurement
  • The target BP should remain to lower BP in most hypertensive patients to <140/90 mmHG.
  • The higher cardiovascular risk: SPRINT eligible patients
    • Target SBP should be <120mmHG using AOBP
  • Others including DM, CKD with overt proteinuria
    • Target BPs should not be changed
  • The balance between benefits and risks should be taken into account for the practice of personalized medicine.
    • If tolerated well, one could attempt to go lower incrementally with careful monitoring.

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website:


Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp